To confirm the inhibitory effect of metformin on the self-renewal of tumor-initiating HCC cells, we conducted immunocytochemical analyses of the expression of EpCAM and α-fetoprotein (AFP), hepatic stem/progenitor cell markers, in the resultant spheres. Here, EPCAM is linked to hepatocellular carcinoma.